What is J B Chemicals & Pharmaceuticals Ltd (JBCHEPHARM) share price today?

J B Chemicals & Pharmaceuticals Ltd (JBCHEPHARM) is listed on the NSE. Visit VestAI at https://www.vestai.io/stocks/JBCHEPHARM for the latest live price, technical analysis, and AI-powered insights.

How to analyse JBCHEPHARM stock?

VestAI provides comprehensive JBCHEPHARM stock analysis including RSI, MACD, Bollinger Bands, SMA trend, ROCE, debt-to-equity ratio, and smart money holdings by superstar investors.

What sector is J B Chemicals & Pharmaceuticals Ltd in?

J B Chemicals & Pharmaceuticals Ltd (JBCHEPHARM) is in the Healthcare sector, Pharmaceuticals industry on the NSE.

J B Chemicals & Pharmaceuticals Ltd

Name: J B Chemicals & Pharmaceuticals Ltd (JBCHEPHARM) Financial Metrics
Creator: VestAI

JBCHEPHARM

NSE· Healthcare

₹2,408.90

+0.00 (+0.00%)

Updated 11:27 am IST

52W Low · ₹1,638.5052W High · ₹2,525.50

Near 52W High

Market Cap

₹34830.00L Cr

Volume

47.79L

Prev Close

₹2,506.00

ISIN

INE572A01036

Orion Score

Fundamentals-based quality & risk · not a recommendation

68/100

Quality

J B Chemicals & Pharmaceuticals Ltd scores 68/100 (Quality) on the Orion Score — strong business quality (75), strong growth (80), strong balance-sheet safety (81) and rich valuation (15). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality

Growth

Safety

Value

Full Orion analysis

Risk checks

Profit converts to cash (CFO 0.8× PAT)
Low debt, comfortable interest cover
No distress, manipulation or dilution flags

Forensic accounting

Piotroski F 6/9Altman Z Safe(8.69)Beneish M Clean(-2.58)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

84/100

Strong

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION

Low Debt

D/E 0.00x — lean balance sheet

QUALITY

High Quality

ROCE 20.6% — excellent capital efficiency

MOMENTUM

Bullish

RSI 62.4 — strong momentum

Price Chart

SMA 20

SMA 50

SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio: 48.78
ROCE: 20.58%
ROE (1Y): 18.69%
D/E Ratio: 0.00x
OPM: 16.71%
TTM EPS: ₹44.47
Dividend Yield: 86.00%
Qtrly Sales: ₹904.23 Cr
Qtrly Profit: ₹101.37 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit

Quarter	Revenue	Net Profit	OPM	EPS
Q4 2026	₹904.23	₹101.37	16.7%	₹6.32
Q3 2026	₹1,064.72	₹197.89	23.5%	₹12.45
Q2 2026	₹1,084.9	₹207.82	24.4%	₹13.08
Q1 2026	₹1,093.94	₹202.38	23.6%	₹12.75
Q4 2025	₹949.48	₹145.69	19.0%	₹9.17

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit

Year	Revenue	Net Profit	EBITDA	OPM
FY 2026	₹4,076.2	₹709.47	₹1,140.28	22.1%
FY 2025	₹3,862.04	₹659.58	₹1,069.12	22.1%
FY 2024	₹3,447.67	₹552.63	₹933.48	21.8%
FY 2023	₹3,116.51	₹409.84	₹705.05	18.9%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

Company	Mkt Cap	P/E	ROCE	ROE	D/E	OPM
JBCHEPHARM ★	₹34,830 Cr	48.78	20.58%	18.69%	0.00x	16.71%
SUNPHARMASun Pharmaceutical Industries	₹4,27,609 Cr	37.32	15.73%	14.72%	0.06x	18.90%
MAXHEALTHMax Healthcare Institute	₹95,110 Cr	66.21	11.94%	14.33%	0.32x	22.56%
AUROPHARMAAurobindo Pharma Limited	₹90,029 Cr	25.94	12.55%	9.93%	0.21x	15.11%
ABBOTINDIAAbbott India Limited	₹57,724 Cr	36.63	36.14%	34.46%	0.04x	27.01%
AJANTPHARMAjanta Pharma Limited	₹41,836 Cr	39.55	27.99%	25.39%	0.06x	51.40%

Balance Sheet

All values in ₹ Crores

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	₹4,273.78	₹3,994.13	₹3,553.87	₹2,607.4
Equity	₹3,433.32	₹2,923.33	₹2,480.35	₹2,134.12
Total Debt	₹27.89	₹377.66	₹572.45	₹54.56
Cash	₹115.09	₹88.22	₹76.93	₹56.54
Net Debt	—	₹268.93	₹471.3	—
Working Capital	₹1,290.4	₹985.12	₹973.58	₹891.14

Shareholding Pattern

Q1 FY2027

Promoter

49.24%

FII

15.56%

DII

12.73%

Public

22.47%

Quarter-over-Quarter Trend

Quarter	Promoter	FII	DII	Public
Q1 FY2027	49.24% ↑	15.56% ↑	12.73% ↓	22.47% ↑
Q3 FY2026	47.55% ↓	14.88% ↓	23.35% ↑	14.21% ↓
Q2 FY2026	47.56% ↓	15.31% ↓	22.83% ↑	14.31% ↓
Q1 FY2026	47.73% ↓	17.77% ↓	19.62% ↑	14.87% ↓
Q4 FY2025	47.84% ↓	18.3% ↑	18.71% ↑	15.13% ↓
Q3 FY2025	53.66% ↓	14.64% ↑	16.4% ↓	15.29% ↓
Q2 FY2025	53.74% ↓	13.63% ↑	16.81% ↓	15.8% ↓
Q1 FY2025	53.77%	12.17%	17.61%	16.42%

Corporate Actions

Ex-Date	Action	Details
2026-07-17	OTHER	Merger
2026-05-29	DIVIDEND	Dividend - Rs 9.30 Per Share
2026-02-11	DIVIDEND	Interim Dividend - Rs 12.70 Per Share

Analyse JBCHEPHARM with Orion AI

Ask: "Is J B Chemicals & Pharmaceuticals Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About J B Chemicals & Pharmaceuticals Ltd (JBCHEPHARM) Stock

J B Chemicals & Pharmaceuticals Ltd is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE572A01036. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.